Description: Figure 14 shows the odds ratios for the meta-analyses on low-dose estrogen formulation. Compared with never use, the odds ratio for low-dose estrogen-containing OCs was 0.50 (95% CI, 0.30 to 0.85)

Figure 14Forest plot for low-dose estrogen (ovarian cancer incidence)

CI = confidence interval; OC = oral contraceptive

From: 2, Oral Contraceptives and Ovarian Cancer

Cover of Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer
Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer.
Evidence Reports/Technology Assessments, No. 212.
Havrilesky LJ, Gierisch JM, Moorman PG, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.